BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9750007)

  • 1. Porcine carotid vascular effects of eletriptan (UK-116,044): a new 5-HT1B/1D receptor agonist with anti-migraine activity.
    Willems E; De Vries P; Heiligers JP; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):212-9. PubMed ID: 9750007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antimigraine agent alniditan selectively constricts porcine carotid arteriovenous anastomoses via 5-HT1B/1D receptors.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Eur J Pharmacol; 1998 Jun; 351(2):193-201. PubMed ID: 9687003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of avitriptan, a new 5-HT 1B/1D receptor agonist, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Wang W; Heiligers JP; Maassen vandenBrink A; Bax WA; Yocca FD
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):295-302. PubMed ID: 9050026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BMS-181885, a 5-HT1B/1D receptor ligand, in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Heiligers JP; Bax WA; Maassen VanDenBrink A; Yocca FD
    Eur J Pharmacol; 1998 Jun; 351(3):329-39. PubMed ID: 9721025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of donitriptan on carotid haemodynamics and cardiac output distribution in anaesthetized pigs.
    Tom B; De Vries P; Heiligers JP; Willems EW; Kapoor K; John GW; Saxena PR
    Cephalalgia; 2002 Feb; 22(1):37-47. PubMed ID: 11993612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the role of 5-HT1B and 5-HT1D receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses.
    De Vries P; Willems EW; Heiligers JP; Villalón CM; Saxena PR
    Br J Pharmacol; 1999 May; 127(2):405-12. PubMed ID: 10385240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors.
    De Vries P; Villalón CM; Heiligers JP; Saxena PR
    Br J Pharmacol; 1998 Apr; 123(8):1561-70. PubMed ID: 9605562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cranial vascular effects of zolmitriptan, a centrally active 5-HT1B/1D receptor partial agonist for the acute treatment of migraine.
    MacLennan SJ; Cambridge D; Whiting MV; Marston C; Martin GR
    Eur J Pharmacol; 1998 Nov; 361(2-3):191-7. PubMed ID: 9865508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological evidence that alpha1-and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs.
    Willems EW; Trion M; De Vries P; Heiligers JP; Villalón CM; Saxena PR
    Br J Pharmacol; 1999 Jul; 127(5):1263-71. PubMed ID: 10455274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan.
    den Boer MO; Villalón CM; Heiligers JP; Humphrey PP; Saxena PR
    Br J Pharmacol; 1991 Feb; 102(2):323-30. PubMed ID: 1849764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of porcine carotid vascular response to sumatriptan by GR 127935, a selective 5-HT1D receptor antagonist.
    De Vries P; Heiligers JP; Villalón CM; Saxena PR
    Br J Pharmacol; 1996 May; 118(1):85-92. PubMed ID: 8733580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryl trinitrate.
    Lambert GA; Boers PM; Hoskin KL; Donaldson C; Zagami AS
    Brain Res; 2002 Oct; 953(1-2):181-8. PubMed ID: 12384251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of S20749, a close analogue of sumatriptan, on porcine carotid haemodynamics and human isolated coronary artery.
    Saxena PR; Maassen vandenBrink A; Heiligers JP; Scalbert E; Lemaitre BG
    Pharmacol Toxicol; 1996 Oct; 79(4):199-204. PubMed ID: 8899861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unravelling the pharmacological profile of the canine external carotid vasodilator '5-HT1-like' receptors: coexistence of sympatho-inhibitory 5-HT1B and postjunctional 5-HT7 receptors.
    Villalón CM; Sánchez-López A; Centurión D; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):73-80. PubMed ID: 11191839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological, pharmacokinetic and clinical profile of eletriptan (Relpax), a new triptan for migraine].
    Omote M
    Nihon Yakurigaku Zasshi; 2003 Jul; 122(1):93-101. PubMed ID: 12843576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1-like receptor mediated changes in porcine carotid haemodynamics: are 5-HT1D receptors involved?
    Den Boer MO; Villalón CM; Saxena PR
    Naunyn Schmiedebergs Arch Pharmacol; 1992 May; 345(5):509-15. PubMed ID: 1326717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigations with GMC2021 in experimental models predictive of antimigraine activity and coronary side-effect potential.
    Saxena PR; De Vries P; Heiligers JP; Maassen VanDenBrink A; Bax WA; Barf T; Wikström H
    Eur J Pharmacol; 1996 Sep; 312(1):53-62. PubMed ID: 8891578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.
    Napier C; Stewart M; Melrose H; Hopkins B; McHarg A; Wallis R
    Eur J Pharmacol; 1999 Mar; 368(2-3):259-68. PubMed ID: 10193663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F 11356, a novel 5-hydroxytryptamine (5-HT) derivative with potent, selective, and unique high intrinsic activity at 5-HT1B/1D receptors in models relevant to migraine.
    John GW; Pauwels PJ; Perez M; Halazy S; Le Grand B; Verscheure Y; Valentin JP; Palmier C; Wurch T; Chopin P; Marien M; Kleven MS; Koek W; Assie MB; Carilla-Durand E; Tarayre JP; Colpaert FC
    J Pharmacol Exp Ther; 1999 Jul; 290(1):83-95. PubMed ID: 10381763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.